Grail Inc GRAL

US Biotechnology

$126.89 ▲ +1.34% (+$1.68)

🎯 52W High 🔥 High Short Interest 🎢 High Beta

Open $123.50

Prev Close $125.21

Day Range $118.45 – $127.67

52W Range $41.50 – $126.81

Market Cap $5.67B

Beta 1.62

EPS (TTM) $-9.75

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2024-06-12
Shares Out.	42,920,000
Website	grail.com/ ↗
Phone	13026587581
Employees	910
Revenue	$44.7M
Gross Profit	-$12.6M
Net Income	-$110.2M
Free Cash Flow	-$296.2M
Total Assets	$2.84B
Total Liabilities	$301.0M
Equity	$2.54B

About Grail Inc

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Grail Inc is a publicly traded company under the ticker symbol GRAL on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.